Study examines the link between oropharyngeal cancer and high-risk sexual behavior

FHS
July 15, 2023
12:07 am

The development of head and neck cancer is increasingly linked to HPV infection, which is a sexually transmitted disease.

Roche to take on Abbott, Dexcom with its first CGM

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Roche shared details of its

March 7, 2024

Antengene, Hansoh partner to commercialise XPOVIO in China

XPOVIO is the world’s first approved orally available selective inhibitor of the nuclear export protein XPO1. Credit: Nemes Laszlo / Shutterstock.com. Antengene has signed a

August 11, 2023

Identifying risks and solutions: study uncovers correlates of protection against COVID-19

Study identified correlates of protection healthy individuals who have received three doses of Pfizer- BNT162b2 vaccine.

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.